Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/176410
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGiorgetti, Alessandra-
dc.contributor.authorMontserrat, Núria-
dc.contributor.authorAasen, Trond-
dc.contributor.authorGonzalez, Federico-
dc.contributor.authorRodríguez-Pizà, Ignacio-
dc.contributor.authorVassena, Rita-
dc.contributor.authorRaya Chamorro, Ángel-
dc.contributor.authorBoué, Stefanie-
dc.contributor.authorBarrero, Maria J.-
dc.contributor.authorAran Corbella, Begoña-
dc.contributor.authorTorrabadella, Marta-
dc.contributor.authorVeiga, Anna-
dc.contributor.authorIzpisúa Belmonte, Juan Carlos-
dc.date.accessioned2021-04-20T11:39:29Z-
dc.date.available2021-04-20T11:39:29Z-
dc.date.issued2009-10-02-
dc.identifier.issn1934-5909-
dc.identifier.urihttp://hdl.handle.net/2445/176410-
dc.description.abstractMouse and human fibroblasts were the first cell types successfully reprog- rammed by ectopic expression of OCT4, SOX2, KLF4, and c-MYC (OSKM) (Lowry et al., 2008; Maherali et al., 2007; Park et al., 2008; Takahashi et al., 2007; Taka- hashi and Yamanaka, 2006; Yu et al., 2007). Further studies have shown that the age, origin, and cell type used have a deep impact on the reprogramming effi- ciency, eventually requiring the expres- sion of fewer factors and/or reducing the timing of the whole process. In general, stem cells are rare and difficult to access and isolate in large numbers (neural stem cells, for instance [Kim et al., 2008, 2009c]) and, therefore, represent a com- plicated target for reprogramming. How- ever, Cord Blood (CB) could represent an alternative and readily accessible source of stem cells. Here, we describe reprog- ramming of CB cells to pluripotency by retroviral transduction of four (OSKM), three (OSK), and as few as two (OS) tran- scription factors, without the need for additional chemical compounds.-
dc.format.extent10 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherElsevier B.V.-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.stem.2009.09.008-
dc.relation.ispartofCell Stem Cell, 2009, vol. 5, num. 4, p. 353-357-
dc.relation.urihttps://doi.org/10.1016/j.stem.2009.09.008-
dc.rights(c) Elsevier B.V., 2009-
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)-
dc.subject.classificationCèl·lules mare-
dc.subject.classificationCordó umbilical-
dc.subject.classificationCitologia-
dc.subject.otherStem cells-
dc.subject.otherUmbilical cord-
dc.subject.otherCytology-
dc.titleGeneration of induced pluripotent stem cells from human cord blood using OCT4 and SOX2-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.identifier.idgrec711108-
dc.date.updated2021-04-20T11:39:29Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid19796614-
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)

Files in This Item:
File Description SizeFormat 
711108.pdf1.26 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.